Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction
Authors:
- M. LabelleMLM. Labelle
- 1 February 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (3) , 283-288
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The discovery of L-699,392, a novel potent and orally active leukotriene D4 receptor antagonistBioorganic & Medicinal Chemistry Letters, 1994
- Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesisHepatology, 1993
- Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonistsToxicology and Applied Pharmacology, 1992
- The discovery of a new structural class of potent orally active leukotriene D4 antagonistsBioorganic & Medicinal Chemistry Letters, 1992
- Lung function improvement in asthma with a cysteinylleukotriene receptor antagonistThe Lancet, 1991
- 677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthmaJournal of Allergy and Clinical Immunology, 1991
- Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopinCarcinogenesis, 1990
- Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 miceFundamental and Applied Toxicology, 1990
- Induction of peroxisomal β-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: Structure-activity relationshipsToxicology and Applied Pharmacology, 1989
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980